We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Finch Therapeutics Group Inc
9 own
15 watching
Current Price
$0.52
$0.05
(9.47%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
24.87M
52-Week High
9.28
52-Week Low
0.3001
Average Volume
0.38M
Dividend Yield
--
P/E Ratio
--
Market Capitalization24.87M52-Week High9.2852-Week Low0.3001Average Volume0.38MDividend Yield--P/E Ratio--What does the Finch Therapeutics Group Inc do?
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company s lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides difficile infection, as well as for the treatment of chronic hepatitis B virus. It is also developing FIN-211, an orally administered enriched consortia product candidate for use in the treatment of autism spectrum disorder; and TAK-524 and FIN-525, which are orally administered targeted consortia product candidates for the treatment of ulcerative colitis and Crohn's disease. The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; Skysong Innovations LLC; and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Somerville, Massachusetts.
Read More
How much money does Finch Therapeutics Group Inc make?
News & Events about Finch Therapeutics Group Inc.
Globe Newswire
6days ago
SOMERVILLE, Mass., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (the Company, Finch, or Finch Therapeutics) (Nasdaq: FNCH) today announced its decision to discontinue the PRISM4 Phase 3 trial of CP101 in recurrent C. difficile infection (CDI) and focus on realizing the value of ...
Globe Newswire
2 months ago
SOMERVILLE, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (Finch or Finch Therapeutics) (Nasdaq: FNCH), a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery platform to develop a novel class of orally administered biological drugs, today ...
Zolmax
3 months ago
Finch Therapeutics Group, Inc. (NASDAQ:FNCH Get Rating) traded down 3% on Friday . The company traded as low as $1.58 and last traded at $1.59. 11,318 shares changed hands during mid-day trading, a decline of 97% from the average session volume of 344,381 shares. The stock had previously closed at $...
Globe Newswire
8 months ago
SOMERVILLE, Mass., May 09, 2022 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (Finch or Finch Therapeutics) (Nasdaq: FNCH), a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery platform to develop a novel class of orally administered biological drugs, today ...
PR Newswire
9 months ago
Thinking about buying stock in Finch Therapeutics, Zymeworks, DiDi Global, Bilibili, or IQIYI? Thinking about buying stock in Finch Therapeutics, Zymeworks, DiDi Global, Bilibili, or IQIYI? PR Newswire NEW YORK, April 29, 2022 NEW YORK, April 29, 2022 /PRNewswire/ -- InvestorsObserverissues...
Frequently Asked Questions
Frequently Asked Questions
What is Finch Therapeutics Group Inc share price today?
Can Indians buy Finch Therapeutics Group Inc shares?
How can I buy Finch Therapeutics Group Inc shares from India?
Can Fractional shares of Finch Therapeutics Group Inc be purchased?
What are the documents required to start investing in Finch Therapeutics Group Inc stocks?
What is today’s traded volume of Finch Therapeutics Group Inc?
What is today’s market capitalisation of Finch Therapeutics Group Inc?
What is the 52-Week High and Low Range of Finch Therapeutics Group Inc?
What percentage is Finch Therapeutics Group Inc down from its 52-Week High?
What percentage is Finch Therapeutics Group Inc up from its 52-Week Low?
Current Price
$0.52
$0.05
(9.47%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.